Next 10 |
home / stock / bthcf / bthcf news
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenpro...
VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Mar...
VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that it will...
VANCOUVER, British Columbia, Dec. 09, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that it plan...
Thinly traded nano cap Algernon Pharmaceuticals ( OTCQB:BTHCF ) is up 29% in early trade, albeit on turnover of only 19K shares, in reaction to its announcement of "positive" results from a cough study conducted by CRO outfit Pharmidex in a guinea pig citric acid challenge mode...
VANCOUVER, British Columbia, Dec. 05, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that NP-120 ...
VANCOUVER, B.C., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to provide an update to the market o...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Nov. 01, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (“ Algernon ” or the “ Company ”) ( CSE: AGN ) ( FRANKFURT: AGW ) (...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (“ Algernon ” or “ Company ”) ( CSE: AGN ) ( FRANKFURT: AGW ) ( OTC...
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (“ Algernon ” or “ Company ”) ( CSE: AGN ) ( FRANKFURT: AGW ) ( OTCB...
News, Short Squeeze, Breakout and More Instantly...
Breathtec Biomedical Inc Company Name:
BTHCF Stock Symbol:
OTCMKTS Market:
VANCOUVER, British Columbia, May 12, 2021 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”) a clinical stage pharmaceutical development company announces that NP-120 (Ifenpro...
VANCOUVER, British Columbia, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that Dr. Mar...
VANCOUVER, British Columbia, Dec. 10, 2019 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCB: BTHCF) (the “ Company ” or “ Algernon ”), a clinical stage pharmaceutical development company, is pleased to announce that it will...